Assess whether to re-trade, restructure, or drop from regulatory-approval

SITUATION The working file is regulatory-approval critical-path calendar after a customer who just sent a non-renewal. Buy-side QoE lead in a PE platform evaluating a founder-led SaaS add-on has to name To re-trade, restructure, or Drop for this M&A Due Diligence Earnings and Revenue Quality file.

DECISION Buy-side QoE lead in a PE platform evaluating a founder-led SaaS add-on must choose To re-trade, restructure, / Drop using regulatory-approval critical-path calendar after a customer who just sent a non-renewal.

HYPOTHESES TO TEST 1. A customer who just sent a non-renewal is noise around an already-controlled Earnings and Revenue Quality process in a PE platform evaluating a founder-led SaaS add-on, given regulatory-approval critical-path calendar. 2. A customer who just sent a non-renewal is the event in regulatory-approval critical-path calendar that forces To re-trade, restructure, for buy-side QoE lead under M&A Due Diligence. 3. Regulatory-approval critical-path calendar shows a one-file miss after a customer who just sent a non-renewal, not a Earnings and Revenue Quality program failure. 4. Regulatory-approval critical-path calendar cannot decide to re-trade, restructure, or drop yet after a customer who just sent a non-renewal; hold is the only M&A Due Diligence close a PE platform evaluating a founder-led SaaS add-on can defend.

ANALYSIS REQUIRED 1. Test whether a customer who just sent a non-renewal is a diligence gap, a price chip, or a walk-away. 2. Separate a one-off add-back from a recurring earnings issue in regulatory-approval critical-path calendar. 3. Map reps, earnout mechanics, and integration risk a PE platform evaluating a founder-led SaaS add-on would inherit. 4. For this M&A Due Diligence Earnings and Revenue Quality file, read regulatory-approval critical-path calendar against a customer who just sent a non-renewal and write the one fact that would move to re-trade, restructure, or drop for buy-side QoE lead.

RECOMMENDATION Choose To re-trade, restructure, / Drop on this M&A Due Diligence / Earnings and Revenue Quality packet (regulatory-approval critical-path calendar after a customer who just sent a non-renewal). If regulatory-approval critical-path calendar cannot force a M&A Due Diligence label under Earnings and Revenue Quality, stop. Do not invent missing evidence a PE platform evaluating a founder-led SaaS add-on does not have.

COMMAND RETURNS - Bottom-line M&A Due Diligence option on to re-trade, restructure, or drop, then the evidence in regulatory-approval critical-path calendar, then the action for buy-side QoE lead - Hypothesis scorecard against regulatory-approval critical-path calendar: supported / rejected / untestable - Owner and next date for buy-side QoE lead in a PE platform evaluating a founder-led SaaS add-on - What changes to re-trade, restructure, or drop if a customer who just sent a non-renewal is later withdrawn